Companies: 10,795·Total market cap: $144.5T

Imagion Biosystems Limited

Imagion Biosystems Limited

IBXXFOTCHealthcare● Active

$0.03

+$0.00(+0.00%)

Market Cap$6626738

P/E Ratio—

52W High$0.04

52W Low$0.008

Avg Volume4K

Open$0.02

Beta-0.21

Net Income Financials Revenue

Imagion Biosystems Limited (IBXXF) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

IBXXF · net income · updated Jun 15, 2026

Core profitability metrics

IBXXF · net income · margin · TTM · CAGR

Net income was −$4.3M for FY2025 (fiscal year ending 2025-12-31), down 108.4% year-over-year. Net profit margin was —.

FY2025 Net Income−$4.3M▼ -108.4% YoY

Trailing 12M (TTM)−$6.4Mtrailing 4 quarters sum

Net Profit Margin——

YoY Change-108.4%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 15, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · IBXXF net income history · IBXXF profit margin

Annual net income data

IBXXF · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$4.3M▼ 108.4%—$0

FY2024Loss−$2.1M▲ +83.4%-77.6%$2.7M

FY2023Loss−$12.5M▼ 27.2%-250.9%$5.0M

FY2022Loss−$9.8M▼ 62.8%-319.4%$3.1M

FY2021Loss−$6.0M▼ 12.3%-211.0%$2.9M

Net income vs peers (Healthcare)

IBXXF vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Imagion Biosystems LimitedYOU

IBXXF

−$4.3M-108.4%—

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Imagion Biosystems Limited (IBXXF) reported net income of −$4.3M for FY2025 (fiscal year ending 2025-12-31), down 108.4% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Imagion Biosystems Limited has not yet achieved annual profitability based on available data (12 fiscal years). The company has reported net losses across all available periods.

Imagion Biosystems Limited's net profit margin was — for FY2025, based on the latest annual results.

Investors sometimes search for "Imagion Biosystems Limited net worth" — the company's market capitalization is a separate figure from IBXXF net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

IBXXF net income · 4 questions

Imagion Biosystems Limited is not currently profitable on an annual basis. The company reported a net loss of $4.3M for FY2025.

is IBXXF profitabledoes IBXXF make a profitIBXXF profitabilityIBXXF profitable company

▸ Source: FMP /income-statement · GAAP · Imagion Biosystems Limited · Imagion Biosystems Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026